These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21123389)

  • 1. Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus.
    Hofmeister Y; Planitzer CB; Farcet MR; Teschner W; Butterweck HA; Weber A; Holzer GW; Kreil TR
    J Virol; 2011 Feb; 85(4):1896-9. PubMed ID: 21123389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.
    Goo L; Debbink K; Kose N; Sapparapu G; Doyle MP; Wessel AW; Richner JM; Burgomaster KE; Larman BC; Dowd KA; Diamond MS; Crowe JE; Pierson TC
    Nat Microbiol; 2019 Jan; 4(1):71-77. PubMed ID: 30455471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baboon model for West Nile virus infection and vaccine evaluation.
    Wolf RF; Papin JF; Hines-Boykin R; Chavez-Suarez M; White GL; Sakalian M; Dittmer DP
    Virology; 2006 Nov; 355(1):44-51. PubMed ID: 16904151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.
    Muraki Y; Fujita T; Matsuura M; Fuke I; Manabe S; Ishikawa T; Okuno Y; Morita K
    Virol J; 2015 Apr; 12():54. PubMed ID: 25889682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection.
    Ben-Nathan D; Gershoni-Yahalom O; Samina I; Khinich Y; Nur I; Laub O; Gottreich A; Simanov M; Porgador A; Rager-Zisman B; Orr N
    BMC Infect Dis; 2009 Feb; 9():18. PubMed ID: 19222853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
    Chu JH; Chiang CC; Ng ML
    J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector functions of camelid heavy-chain antibodies in immunity to West Nile virus.
    Daley LP; Kutzler MA; Bennett BW; Smith MC; Glaser AL; Appleton JA
    Clin Vaccine Immunol; 2010 Feb; 17(2):239-46. PubMed ID: 19955323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with non-lethal West Nile virus Eg101 strain induces immunity that protects mice against the lethal West Nile virus NY99 strain.
    Kumar M; O'Connell M; Namekar M; Nerurkar VR
    Viruses; 2014 Jun; 6(6):2328-39. PubMed ID: 24915459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.
    Gershoni-Yahalom O; Landes S; Kleiman-Shoval S; Ben-Nathan D; Kam M; Lachmi BE; Khinich Y; Simanov M; Samina I; Eitan A; Cohen IR; Rager-Zisman B; Porgador A
    Immunology; 2010 Aug; 130(4):527-35. PubMed ID: 20331473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis.
    Srivastava R; Ramakrishna C; Cantin E
    J Gen Virol; 2015 Jun; 96(Pt 6):1347-1357. PubMed ID: 25667322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.
    De Filette M; Soehle S; Ulbert S; Richner J; Diamond MS; Sinigaglia A; Barzon L; Roels S; Lisziewicz J; Lorincz O; Sanders NN
    PLoS One; 2014; 9(2):e87837. PubMed ID: 24503579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of antibody protection against West Nile virus.
    Mehlhop E; Diamond MS
    Curr Top Microbiol Immunol; 2008; 317():125-53. PubMed ID: 17990792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
    Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI
    Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.
    Shrestha B; Ng T; Chu HJ; Noll M; Diamond MS
    Vaccine; 2008 Apr; 26(16):2020-33. PubMed ID: 18339459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the protective ability of plasma from Japanese individuals against mosquito-borne viral infections.
    Shinohara N; Owada T; Matsumoto C; Uchida S; Nagai T; Satake M; Tadokoro K
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):393-401. PubMed ID: 29294131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
    Spohn G; Jennings GT; Martina BE; Keller I; Beck M; Pumpens P; Osterhaus AD; Bachmann MF
    Virol J; 2010 Jul; 7():146. PubMed ID: 20604940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.
    Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG
    Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
    Magnusson SE; Karlsson KH; Reimer JM; Corbach-Söhle S; Patel S; Richner JM; Nowotny N; Barzon L; Bengtsson KL; Ulbert S; Diamond MS; Stertman L
    Vaccine; 2014 Feb; 32(7):800-8. PubMed ID: 24380682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.